Hyperfine (NASDAQ:HYPR – Free Report) had its price objective reduced by B. Riley from $1.50 to $1.20 in a research note released on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.
Separately, Wells Fargo & Company lifted their price target on shares of Hyperfine from $1.10 to $1.29 and gave the stock an “equal weight” rating in a report on Tuesday, March 18th.
View Our Latest Stock Report on Hyperfine
Hyperfine Price Performance
Hyperfine (NASDAQ:HYPR – Get Free Report) last issued its quarterly earnings results on Monday, March 17th. The company reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.02. The business had revenue of $2.32 million during the quarter, compared to the consensus estimate of $2.30 million. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. During the same period in the previous year, the firm posted ($0.15) earnings per share. On average, analysts anticipate that Hyperfine will post -0.57 EPS for the current year.
Institutional Investors Weigh In On Hyperfine
Institutional investors have recently bought and sold shares of the stock. Virtu Financial LLC purchased a new stake in Hyperfine in the fourth quarter valued at approximately $25,000. Graypoint LLC purchased a new stake in Hyperfine in the fourth quarter valued at approximately $44,000. Wealth Enhancement Advisory Services LLC grew its holdings in Hyperfine by 64.3% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock valued at $72,000 after purchasing an additional 32,093 shares during the period. Renaissance Technologies LLC grew its holdings in Hyperfine by 32.9% in the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock valued at $187,000 after purchasing an additional 52,500 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Hyperfine by 18.7% in the third quarter. Geode Capital Management LLC now owns 624,520 shares of the company’s stock valued at $675,000 after purchasing an additional 98,335 shares during the period. 15.03% of the stock is currently owned by hedge funds and other institutional investors.
Hyperfine Company Profile
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
See Also
- Five stocks we like better than Hyperfine
- What Investors Need to Know to Beat the Market
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- What is the Euro STOXX 50 Index?
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.